Home > Qtrly Results > VENUS REMEDIES

VENUS REMEDIES
Quarterly Results Analysis [Dec2023]

COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results

VENUS REMEDIES Quarterly Results

Consolidated Dec2023
UnAudited
Sep2023
UnAudited
Jun2023
UnAudited
Mar2023
UnAudited
Dec2022
UnAudited
Sep2022
UnAudited
Jun2022
UnAudited
Mar2022
UnAudited
Revenues ₹143 Cr ₹168 Cr ₹95 Cr ₹156 Cr ₹117 Cr ₹140 Cr ₹143 Cr ₹142 Cr
Expenses ₹131 Cr ₹150 Cr ₹85 Cr ₹131 Cr ₹109 Cr ₹127 Cr ₹129 Cr ₹137 Cr
Operating Income ₹12 Cr ₹18 Cr ₹10 Cr ₹25 Cr ₹8 Cr ₹13 Cr ₹15 Cr ₹6 Cr
Other Income ₹2 Cr ₹3 Cr ₹2 Cr ₹3 Cr ₹4 Cr ₹2 Cr ₹1 Cr ₹2 Cr
Interest ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr
Depreciation ₹7 Cr ₹6 Cr ₹8 Cr ₹8 Cr ₹7 Cr ₹9 Cr ₹8 Cr ₹8 Cr
Profit Before Tax ₹8 Cr ₹14 Cr ₹5 Cr ₹20 Cr ₹5 Cr ₹6 Cr ₹8 Cr ₹0 Cr
Profit After Tax ₹7 Cr ₹10 Cr ₹1 Cr ₹11 Cr ₹3 Cr ₹5 Cr ₹7 Cr ₹0 Cr
EPS ₹5.12 ₹7.43 ₹0.88 ₹8.27 ₹2.46 ₹3.99 ₹5.15 ₹0.17
Industry Peers & Returns1W1M1Y
VENUS REMEDIES -4% -12.1% 89.2%
SUN PHARMACEUTICAL INDUSTRIES 3% 2.3% 68.2%
CIPLA 2.5% 0.4% 71.7%
DR REDDYS LABORATORIES -0.2% -4.9% 40.3%
ZYDUS LIFESCIENCES 5% 10.4% 109.1%
DIVIS LABORATORIES -1.6% -7% 23.8%
MANKIND PHARMA NA NA NA
TORRENT PHARMACEUTICALS 2.9% -2.2% 69%
LUPIN 2.8% 0% 147.8%

VENUS REMEDIES Quarterly Revenues

Revenues
Q-o-Q

-14.49 %

Y-o-Y

22.69 %

Quarters Revenues % Change
Dec2023 ₹143 Cr
-14.49
Sep2023 ₹168 Cr
76.27
Jun2023 ₹95 Cr
-38.87
Mar2023 ₹156 Cr
33.14
Dec2022 ₹117 Cr
-16.43
Sep2022 ₹140 Cr
-2.23
Jun2022 ₹143 Cr
0.44
Mar2022 ₹142 Cr -

VENUS REMEDIES Quarterly Operating Profit

Operating Profit
Q-o-Q

-32.32 %

Y-o-Y

48.64 %

Quarters Operating Profit % Change
Dec2023 ₹12 Cr
-32.32
Sep2023 ₹18 Cr
71.06
Jun2023 ₹10 Cr
-57.74
Mar2023 ₹25 Cr
203.83
Dec2022 ₹8 Cr
-37.55
Sep2022 ₹13 Cr
-10.61
Jun2022 ₹15 Cr
161.91
Mar2022 ₹6 Cr -
Operating Margins
Q-o-Q

-20.92 %

Y-o-Y

21.07 %

Quarters Operating Margin% % Change
Dec2023 8.39%
-20.92
Sep2023 10.61%
-2.93
Jun2023 10.93%
-30.87
Mar2023 15.81%
128.14
Dec2022 6.93%
-25.24
Sep2022 9.27%
-8.58
Jun2022 10.14%
160.67
Mar2022 3.89% -

VENUS REMEDIES Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-31.09 %

Y-o-Y

108.21 %

Quarters Profit After Tax % Change
Dec2023 ₹7 Cr
-31.09
Sep2023 ₹10 Cr
742.37
Jun2023 ₹1 Cr
-89.33
Mar2023 ₹11 Cr
236.17
Dec2022 ₹3 Cr
-38.27
Sep2022 ₹5 Cr
-22.64
Jun2022 ₹7 Cr
2,895.65
Mar2022 ₹0 Cr -
PAT Margins
Q-o-Q

-19.39 %

Y-o-Y

70.11 %

Quarters PAT Margin(%) % Change
Dec2023 4.78 %
-19.39
Sep2023 5.93 %
378.23
Jun2023 1.24 %
-82.56
Mar2023 7.11 %
153.02
Dec2022 2.81 %
-26.25
Sep2022 3.81 %
-20.95
Jun2022 4.82 %
2,912.50
Mar2022 0.16 % -

VENUS REMEDIES Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-31.09 %

Y-o-Y

108.13 %

Quarters EPS % Change
Dec2023 ₹5.12
-31.09
Sep2023 ₹7.43
744.32
Jun2023 ₹0.88
-89.36
Mar2023 ₹8.27
236.18
Dec2022 ₹2.46
-38.35
Sep2022 ₹3.99
-22.52
Jun2022 ₹5.15
2,929.41
Mar2022 ₹0.17 -

You may also like the below Video Courses